King Pharmaceuticals KG European Hospital Liability Quota Share — Total AmTrust Reinsurance PPD
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's european hospital liability quota share — total amtrust reinsurance ppd.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's european hospital liability quota share — total amtrust reinsurance PPD?
- King Pharmaceuticals (KG) reported european hospital liability quota share — total amtrust reinsurance PPD of -$2K in Q1 2026.
- What does european hospital liability quota share — total amtrust reinsurance PPD mean?
- This metric represents the total adverse prior period development (PPD) recognized within the European Hospital Liability Quota Share reinsurance segment. It quantifies the unfavorable adjustments made to previously established loss reserves for claims occurring in prior underwriting years. Monitoring this figure is essential for assessing the adequacy of historical reserving practices and the volatility of long-tail liability risks within this specific portfolio.